SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.80    2.00 (1.31%)
Bid:
154.80
Ask:
155.00
Spread: 0.20 (0.129%)
Market Cap: £885.94m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM Statement

25 Apr 2013 07:00

RNS Number : 1771D
Elementis PLC
25 April 2013
 



 

 

 

25 April 2013

 

 

AGM / Interim Management Statement

 

Elementis plc (ELM.L, "the Company" or "the Group"), the Global Specialty Chemicals Company, today issues its Interim Management Statement for the three months ended 31 March 2013.

 

Commenting on the Company's performance Group Chief Executive, David Dutro, said: "In the first three months of 2013 we have made a solid start to the year, particularly as we are comparing our performance to a very strong quarter in 2012. We continue to benefit from the diverse nature of our business, both in terms of geography and end market. At Elementis we are committed to creating our own growth opportunities in an uncertain economic environment and the Group has a number of exciting growth initiatives that are at an early stage of development, including the new coatings additives plant in North America, as well as the acquisitions of Watercryl in Brazil and Hi-Mar in the US. Each of these should add momentum to our performance as the year progresses. Overall, we anticipate full year earnings will be in line with market expectations."

 

In Specialty Products, sales volumes in the first quarter were 7 per cent higher than the same period last year with good progress in all key business areas.

·; In coatings additives, sales volumes in North America were 3 per cent higher than the previous year, while volumes in Latin America were 134 per cent higher, as each region benefited from the recent acquisitions of Hi-Mar in North America and Watercryl in Latin America. Volumes in Asia Pacific were 4 per cent higher, while in Europe sales volumes grew by 7 per cent as the business continued to succeed in identifying new business opportunities to offset underlying economic weakness.

·; In personal care, sales volumes were 4 per cent higher than the same period last year.

·; Sales volumes in the oil and gas drilling sector improved significantly in the current period compared to the second half of 2012, when an industry inventory adjustment caused a temporary downturn in order patterns. As a result, sales volumes in the first quarter were 61 per cent higher than the average quarterly sales in the second half of 2012 and only 5 per cent below the first quarter of 2012, which was the strongest sales quarter in the business's history.

In Chromium, as expected, first quarter sales were impacted by a scheduled plant maintenance shutdown. The business operates a pro-active maintenance programme, designed to ensure a stable operating performance with extended periods between shutdowns. The previous maintenance shutdown was done during the second half of 2011, so sales in the first quarter of 2012 were unaffected. The most recent maintenance was carried out in the early part of 2013, thereby reducing sales volumes in the first quarter and, as a consequence, sales volumes were 15 per cent lower than the previous year. However, consistent with the strategy for this business of "stable earnings and cash flow", sales for the year as a whole are expected to be similar to 2012.

The Group's balance sheet remains in a strong position and is expected to be in a net cash position at the end of the year.

 

 

Enquiries:

Elementis

+44 (0) 207 408 9300

Brian Taylorson, Finance Director

FTI Consulting

+44 (0) 207 831 3113

Deborah Scott

Matthew Cole

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDGGDSUUDBGXS
Date   Source Headline
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.